You have full text access to this OnlineOpen article

Comparative study between nadolol and 5-isosorbide mononitrate vs. endoscopic band ligation plus sclerotherapy in the prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial

  1. G. ROMERO1,†,
  2. D. KRAVETZ1,†,
  3. J. ARGONZ1,
  4. C. VULCANO1,
  5. A. SUAREZ1,
  6. E. FASSIO2,
  7. N. DOMINGUEZ2,
  8. A. BOSCO2,
  9. A. MUÑOZ1,
  10. P. SALGADO1,
  11. R. TERG1

Article first published online: 10 JUL 2006

DOI: 10.1111/j.1365-2036.2006.03007.x

Issue

Alimentary Pharmacology & Therapeutics

Alimentary Pharmacology & Therapeutics

Volume 24, Issue 4, pages 601–611, August 2006

Additional Information

How to Cite

ROMERO, G., KRAVETZ, D., ARGONZ, J., VULCANO, C., SUAREZ, A., FASSIO, E., DOMINGUEZ, N., BOSCO, A., MUÑOZ, A., SALGADO, P. and TERG, R. (2006), Comparative study between nadolol and 5-isosorbide mononitrate vs. endoscopic band ligation plus sclerotherapy in the prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial. Alimentary Pharmacology & Therapeutics, 24: 601–611. doi: 10.1111/j.1365-2036.2006.03007.x

Author Information

  1. 1

    Liver Unit, Hospital de Gastroenterologia ‘Prof. Bonorino Udaondo’

  2. 2

    Gastroenterology Division, Hospital Nacional ‘ Prof. A Posadas’, Buenos Aires, Argentina

  1. †

    These authors contributed equally to this article.

*Dr D. Kravetz, Division of Gastroenterology, VA San Diego Healthcare System, 3350 La Jolla Village Drive 9111D, San Diego, CA 92161, USA. E-mail: dkravetz@ucsd.edu

  • †

    These authors contributed equally to this article.

Publication History

  1. Issue published online: 10 JUL 2006
  2. Article first published online: 10 JUL 2006
  3. Publication data Submitted 8 February 2006 First decision 12 March 2006 Resubmitted 27 April 2006 Resubmitted 19 May 2006 Accepted 23 May 2006

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (203K)

References

  • 1
    D'Amico G, Morabito A, Pagliaro L, Marubini E, Liver Study Group of Cervello Hospital. Survival and prognostic indicators in compensated and decompensate cirrhosis. Dig Dis Sci 1986; 31: 468–75.
  • 2
    Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981; 80: 800–9.
  • 3
    Pagliaro L, D'Amico G, Pasta L, et al. Portal hypertension in cirrhosis: natural history. In: BoschJ, GroszmannRJ, eds. Portal Hypertension. Pathophysiology and Treatment. Oxford: Blackwell, 1994: 72–92.
  • 4
    Lebrec D, Stiegmann G. Prevention of recurrent variceal haemorrhage (secondary prophylaxis). Portal hypertension. In: RobertoDe Franchis, ed. Proceedings of the Third Baveno International Consensus Workshop. London: Blackwell Science, 2001: 170–8.
  • 5
    D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995; 22: 332–54.
    Direct Link:
  • 6
    Bosch J, Abraldes JG, Groszmann R. Current management of portal hypertension. J Hepatol 2003; 38: 554–8.
  • 7
    Bernard B, Lebrec D, Mathurin P, Opolon P, Poynard T. Beta-adrenergic antagonist in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis. Hepatology 1997; 25: 63–70.
    Direct Link:
  • 8
    Bosch J, Mastai R, Kravetz D, et al. Effects of propranolol on azygos venous blood flow and hepatic and systemic homodynamic in cirrhosis. Hepatology 1984; 4: 1200–5.
    Direct Link:
  • 9
    Groszmann RJ, Bosch J, Grace ND, et al. Hemodynamic events in a prospective randomized trial of propanolol vs. placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990; 99: 1401–7.
  • 10
    Feu F, Gárcia-Págan JC, Luca A, Téres J, Bosch J, Ródes J. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995; 346: 1056–59.
  • 11
    García-Tsao G, Grace N, Groszmann R, et al. Short-term effects of propanolol on portal venous pressure. Hepatology 1986; 6: 101–6.
    Direct Link:
  • 12
    Gárcia-Págan JC, Feu F, Bosch J, Rodés J. Propanolol compared with propanolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: a randomized controlled study. Ann Intern Med 1991; 114: 869–73.
  • 13
    Merkel C, Sacerdoti D, Bolognesi M, et al. Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone. Hepatology 1997; 26: 34–39.
  • 14
    Bureau C, Peron JM, Alric L, et al. ‘A la carte’ treatment of portal hypertension: adapting medical therapy to hemodynamic response for the prevention of bleeding. Hepatology 2002; 36: 1361–6.
  • 15
    Garcia-Págan JC, Navasa M, Bosch J, Bru C, Pizcueta P, Rodés J. Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propanolol administration in patients with cirrhosis. Hepatology 1990; 11: 230–8.
    Direct Link:
  • 16
    Villanueva C, Balanzó J, Novella M, et al. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding. New Engl J Med 1996; 20: 1624–9.
  • 17
    Gournay J, Masliha C, Martin T, Perrin D, Galmiche JP. Isosorbide mononitrate and propanolol compared with propranol alone for the prevention of variceal rebleeding. Hepatology 2000; 31: 1239–45.
    Direct Link:
  • 18
    De Franchis R, Primignani M. Endoscopic treatments for portal hypertension. Semin Liver Dis 1999; 19: 439–55.
  • 19
    Laine L, El Newihi HM, Migikovsky B, Sloane R, Garcia F. Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices. Ann Intern Med 1993; 119: 1–7.
  • 20
    De Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on Definitions, Methodology and Therapeutic Strategies in Portal Hypertension. J Hepatol 2000; 33: 846–52.
  • 21
    Lo GH, Lai KH, Cheng JS, et al. The additive effect of sclerotherapy to patients receiving repeated endoscopic variceal ligation: a prospective, randomized trial. Hepatology 1998; 28: 391–5.
    Direct Link:
  • 22
    Villanueva C, Minana J, Ortiz J, et al. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med 2001; 345: 647–55.
  • 23
    Lo G-H, Chen W-C, Chen M-H, et al. Banding ligation vs. nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding. Gastroenterology 2002; 123: 728–34.
  • 24
    Patch D, Sabin CA, Goulis J, et al. A randomized, controlled trial of medical therapy vs. endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology 2002; 123: 1013–9.
  • 25
    Mela M, Thalheimer U, Burroughs A. Prevention of variceal rebleeding. Approach to management. MedGenMed 2003; 5: 9 (review).
  • 26
    Groszmann RJ, Garcia-Tsao G. Endoscopic variceal banding vs. pharmacological therapy for the prevention of recurrent variceal hemorrhage: what makes the difference? Gastroenterology 2002; 123: 1388–91.
  • 27
    Chalasani N, Kahi C, Francois F, et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 2003; 98: 653–9.
    Direct Link:
  • 28
    Bosch J, Garcia-Pagan JC. Prevention of variceal rebleeding. Lancet 2003; 361: 952–4.
  • 29
    Argonz J, Kravetz D, Suarez A, et al. Variceal band ligation and variceal band ligation plus sclerotherapy in the prevention of recurrent variceal bleeding in cirrhotic patients. A randomized, prospective and controlled trial. Gastrointest Endosc 2000; 51: 157–63.
  • 30
    Hou MC, Lin HC, Kuo BI, Lee FY, Chang FY, Lee SD. The rebleeding course and long-term outcome of esophageal variceal hemorrhage after ligation: comparison with sclerotherapy. Scand J Gastroenterol 1999; 34: 1071–6.
  • 31
    Avgerinos A, Armonis A, Stefanidis G, et al. Sustained rise of portal pressure after sclerotherapy, but not band ligation, in acute variceal bleeding in cirrhosis. Hepatology 2004; 39: 1623–30.
    Direct Link:
  • 32
    Singh P, Pooran N, Indaram A, Bank S. Combined ligation and sclerotherapy vs. ligation alone for secondary prophylaxis of esophageal variceal bleeding: a meta-analysis. Am J Gastroenterol 2002; 97: 623–9.
    Direct Link:
View Full Article (HTML) Get PDF (203K)